Northwest Biotherapeutics Inc (NWBO) Stock Price & News - Google Finance (2024)

Markets

US

Europe

Asia

Currencies

Crypto

Futures

DAX18,622.28-0.37%-69.04DAX18,622.280.37%
FTSE 1008,301.82-0.45%-37.41FTSE 1008,301.820.45%
CAC 408,087.96-0.18%-14.37CAC 408,087.960.18%
IBEX 3511,209.70-0.90%-101.40IBEX 3511,209.700.90%
STOXX 505,018.39-0.38%-19.21STOXX 505,018.390.38%

HomeNWBO • OTCMKTS

Northwest Biotherapeutics Inc

$0.45

May 24, 12:19:54 AM GMT-4 · USD · OTCMKTS · Disclaimer

Key events shows relevant news articles on days with large price movements

Key events shows relevant news articles on days with large price movements

Key events shows relevant news articles on days with large price movements

CytoDyn Inc

$0.24

CYDY1.46%

Anavex Life Sciences Corp

$4.17

AVXL7.33%

Vivos Inc

$0.15

RDGL2.24%

Ardelyx Inc

$7.44

ARDX4.86%

Netlist Inc

$2.07

NLST4.02%

Enzolytics Inc

$0.0035

ENZC3.85%

Kraig Biocraft Laboratories Inc

$0.13

KBLB1.61%

Northwest Bancshares Inc

$11.06

NWBI1.78%

InnerScope Hearing Technologies, Inc.

$0.00024

INND20.00%

Iqstel Inc

$0.30

IQST1.50%

Market news

BTC / GBP1.13%

Bitcoin (BTC / GBP)

Financials

Income Statement

Revenue

Net income

(USD)Mar 2024info

Fiscal Q1 2024 ended 3/31/24.

Y/Y change

Revenue

The total amount of income generated by the sale of goods or services related to the company's primary operations

284.00K-67.73%

Operating expense

Represents the total incurred expenses through normal operations

8.09M15.80%

Net income

Company’s earnings for a period net of operating costs, taxes, and interest

-18.31M-71.91%

Net profit margin

Measures how much net income or profit is generated as a percentage of revenue.

-6.45K-432.69%

Earnings per share

Represents the company's profit divided by the outstanding shares of its common stock.

EBITDA

Earnings before interest, taxes, depreciation, and amortization, is a measure of a company's overall financial performance and is used as an alternative to net income in some circ*mstances

-15.32M-21.28%

Effective tax rate

The percent of their income that a corporation pays in taxes

Total assets

Total liabilities

(USD)Mar 2024info

Fiscal Q1 2024 ended 3/31/24.

Y/Y change

Cash and short-term investments

Investments that are relatively liquid and have maturities between 3 months and one year

2.48M-59.97%

Total assets

The total amount of assets owned by a company

28.57M-13.09%

Total liabilities

Sum of the combined debts a company owes

82.04M26.03%

Total equity

The value of subtracting the total liabilities from the total assets of a company

-53.47M

Shares outstanding

Total number of common shares outstanding as of the latest date disclosed in a financial filing

1.21B

Price to book

A ratio used to determine if a company’s market value is in line with the value of its assets less liabilities and preferred stock

-7.61

Return on assets

A financial ratio that shows a company’s profitability compared to its assets

-139.50%

Return on capital

Company’s return above the average cost it pays for its debt and equity capital

1,336.50%

Net change in cash

(USD)Mar 2024info

Fiscal Q1 2024 ended 3/31/24.

Y/Y change

Net income

Company’s earnings for a period net of operating costs, taxes, and interest

-18.31M-71.91%

Cash from operations

Net cash used or generated for core business activities

-12.41M-10.38%

Cash from investing

Net cash used or generated in investing activities such as purchasing assets

-239.00K82.07%

Cash from financing

Net cash used or generated in financing activities such as dividend payments and loans

12.08M-3.95%

Net change in cash

The amount by which a company's cash balance increases or decreases in an accounting period

352.00K145.48%

Free cash flow

Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments

-5.70M93.32%

Stock

Ownership of a fraction of a corporation and the right to claim a share of the corporation's assets and profits equal to the amount of stock owned

US listed security

Listed on OTCMKTS

Previous close

The last closing price

$0.46

Day range

The range between the high and low prices over the past day

$0.45 - $0.47

Year range

The range between the high and low prices over the past 52 weeks

$0.40 - $1.09

Market cap

A valuation method that multiplies the price of a company's stock by the total number of outstanding shares.

541.78M USD

Avg Volume

The average number of shares traded each day over the past 30 days

1.55M

P/E ratio

The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks

-

Dividend yield

The ratio of annual dividend to current share price that estimates the dividend return of a stock

-

Primary exchange

Listed exchange for this security

OTCMKTS

About

Northwest Biotherapeutics is a development-stage American pharmaceutical company headquartered in Maryland that focuses on developing immunotherapies against different types of cancer. It was founded in 1996 by Alton L. Boynton. Wikipedia

Founded

Jan 1, 1998

Website

Employees

25

Discover more

You may be interested in

info

This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more

IndexFTSE 100 Index8,301.820.45%
IndexDow Jones Industrial Average39,065.261.53%
IndexFTSE 250 Index20,623.860.036%
TSLATesla Inc$173.743.54%
AMZNAmazon.com Inc$181.051.14%
AAPLApple Inc$186.882.11%
LLOYLloyds Banking Group PLCGBX54.622.08%
BARCBarclays PLCGBX213.550.67%
BPBP plcGBX480.050.52%
IndexFTSE All-Share Index4,526.160.39%
IndexBSE SENSEX75,410.390.010%
RRRolls-Royce Holdings PLCGBX440.200.045%
BABAAlibaba Group Holding Ltd - ADR$80.802.27%
IAGInternational Consolidated Airlns Grp SAGBX171.680.19%
IndexNIFTY 5022,957.100.046%
IndexNasdaq-10018,623.390.44%
EZJeasyJet plcGBX455.700.20%

People also search for

CYDYCytoDyn Inc$0.241.46%
AVXLAnavex Life Sciences Corp$4.177.33%
RDGLVivos Inc$0.152.24%
ARDXArdelyx Inc$7.444.86%
NLSTNetlist Inc$2.074.02%
ENZCEnzolytics Inc$0.00353.85%
KBLBKraig Biocraft Laboratories Inc$0.131.61%
NWBINorthwest Bancshares Inc$11.061.78%
INNDInnerScope Hearing Technologies, Inc.$0.0002420.00%
IQSTIqstel Inc$0.301.50%
JAGXJaguar Health Inc$5.1333.26%
XERIXeriant Inc$0.0305.24%
RVVTFRevive Therapeutics Ltd$0.0207.73%
BNGOBioNano Genomics Inc$1.037.21%
KTRAKintara Therapeutics Inc$0.1614.67%
LWLGLightwave Logic Inc$3.198.74%
PLNHPlanet 13 Holdings Inc$0.563.75%
JSDAJones Soda Co ( USA )$0.351.40%

Northwest Biotherapeutics Inc (NWBO) Stock Price & News - Google Finance (7)HelpSend feedbackPrivacyTermsDisclaimer

Northwest Biotherapeutics Inc (NWBO) Stock Price & News - Google Finance (2024)
Top Articles
Latest Posts
Article information

Author: Sen. Emmett Berge

Last Updated:

Views: 6345

Rating: 5 / 5 (80 voted)

Reviews: 95% of readers found this page helpful

Author information

Name: Sen. Emmett Berge

Birthday: 1993-06-17

Address: 787 Elvis Divide, Port Brice, OH 24507-6802

Phone: +9779049645255

Job: Senior Healthcare Specialist

Hobby: Cycling, Model building, Kitesurfing, Origami, Lapidary, Dance, Basketball

Introduction: My name is Sen. Emmett Berge, I am a funny, vast, charming, courageous, enthusiastic, jolly, famous person who loves writing and wants to share my knowledge and understanding with you.